Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-inflammatory therapeutics are drugs used to treat inflammation that occurs after tissues are injured. There are two types of anti-inflammatory therapeutics: one is steroidal anti-inflammatory therapeutics, and the other is non-steroidal anti-inflammatory therapeutics, which are antipyretic and analgesic anti-inflammatory therapeutics referred to in medical practice, such as aspirin.
There are many inflammations that have not yet found a suitable diagnosis and treatment method. The intake of anti-inflammatory therapeutics can greatly reduce the pain caused by inflammation, and the cost is less than that of surgery. However, taking anti-inflammatory therapeutics will bring certain side effects, which hinders the development of the market to a certain extent.
The increasing incidence of chronic inflammation and autoimmune diseases has increased the demand for anti-inflammatory therapeutics. In addition, it is expected that the increasing awareness of anti-inflammatory therapeutics and the active measures of governments in the Asia-Pacific region will drive market growth. The research and development of new anti-inflammatory therapeutics by major developers in the market provides opportunities for the development of the anti-inflammatory therapeutics market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-inflammatory Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-inflammatory Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Anti-inflammatory Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca PLC
GlaxoSmithKline plc
Novartis AG
Eli Lily and Company
Johnson & Johnson
Amgen Inc
By Type:
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
Other
By End-User:
Arthritis
Psoriasis
Respiratory Disease
Multiple Sclerosis
Inflammatory Bowel Disease
Other Inflammatory Disease
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-inflammatory Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2016 to 2027
-
1.3.2 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2016 to 2027
-
1.3.3 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
1.3.4 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
1.3.5 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2016 to 2027
-
1.4.2 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
1.4.3 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2016 to 2027
-
1.4.4 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2016 to 2027
-
1.4.5 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2016 to 2027
-
1.4.6 China Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-inflammatory Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-inflammatory Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
-
3.4.2 Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
-
3.4.3 Market Size and Growth Rate of Corticosteroids
-
3.4.4 Market Size and Growth Rate of Biologics
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Anti-inflammatory Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-inflammatory Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Arthritis
-
4.4.2 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Psoriasis
-
4.4.3 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Respiratory Disease
-
4.4.4 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Multiple Sclerosis
-
4.4.5 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Inflammatory Bowel Disease
-
4.4.6 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Other Inflammatory Disease
5 Market Analysis by Regions
-
5.1 China Anti-inflammatory Therapeutics Production Analysis by Regions
-
5.2 China Anti-inflammatory Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Anti-inflammatory Therapeutics Landscape Analysis
-
6.1 North China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
6.2 North China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
7 Central China Anti-inflammatory Therapeutics Landscape Analysis
-
7.1 Central China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
8 South China Anti-inflammatory Therapeutics Landscape Analysis
-
8.1 South China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
8.2 South China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
9 East China Anti-inflammatory Therapeutics Landscape Analysis
-
9.1 East China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
9.2 East China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Anti-inflammatory Therapeutics Landscape Analysis
-
10.1 Northeast China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Anti-inflammatory Therapeutics Landscape Analysis
-
11.1 Southwest China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Anti-inflammatory Therapeutics Landscape Analysis
-
12.1 Northwest China Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 AstraZeneca PLC
-
13.1.1 AstraZeneca PLC Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 GlaxoSmithKline plc
-
13.2.1 GlaxoSmithKline plc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novartis AG
-
13.3.1 Novartis AG Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lily and Company
-
13.4.1 Eli Lily and Company Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Johnson & Johnson
-
13.5.1 Johnson & Johnson Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Amgen Inc
-
13.6.1 Amgen Inc Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2016 to 2027
-
Figure China Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-inflammatory Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-inflammatory Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-inflammatory Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-inflammatory Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
-
Figure Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
-
Figure Market Size and Growth Rate of Corticosteroids
-
Figure Market Size and Growth Rate of Biologics
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-inflammatory Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-inflammatory Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Arthritis
-
Figure Market Size and Growth Rate of Psoriasis
-
Figure Market Size and Growth Rate of Respiratory Disease
-
Figure Market Size and Growth Rate of Multiple Sclerosis
-
Figure Market Size and Growth Rate of Inflammatory Bowel Disease
-
Figure Market Size and Growth Rate of Other Inflammatory Disease
-
Table China Anti-inflammatory Therapeutics Production by Regions
-
Table China Anti-inflammatory Therapeutics Production Share by Regions
-
Figure China Anti-inflammatory Therapeutics Production Share by Regions in 2016
-
Figure China Anti-inflammatory Therapeutics Production Share by Regions in 2021
-
Figure China Anti-inflammatory Therapeutics Production Share by Regions in 2027
-
Table China Anti-inflammatory Therapeutics Consumption by Regions
-
Table China Anti-inflammatory Therapeutics Consumption Share by Regions
-
Figure China Anti-inflammatory Therapeutics Consumption Share by Regions in 2016
-
Figure China Anti-inflammatory Therapeutics Consumption Share by Regions in 2021
-
Figure China Anti-inflammatory Therapeutics Consumption Share by Regions in 2027
-
Table North China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table North China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Central China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table South China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table South China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table East China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table East China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC
-
Figure Sales and Growth Rate Analysis of AstraZeneca PLC
-
Figure Revenue and Market Share Analysis of AstraZeneca PLC
-
Table Product and Service Introduction of AstraZeneca PLC
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Eli Lily and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily and Company
-
Figure Sales and Growth Rate Analysis of Eli Lily and Company
-
Figure Revenue and Market Share Analysis of Eli Lily and Company
-
Table Product and Service Introduction of Eli Lily and Company
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Amgen Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
-
Figure Sales and Growth Rate Analysis of Amgen Inc
-
Figure Revenue and Market Share Analysis of Amgen Inc
-
Table Product and Service Introduction of Amgen Inc
-
